ArticleHealthcare (Basel, Switzerland)2024

Psychometric Validation of the CLN2 Quality of Life Questionnaire in Participants with CLN2 Disease Treated with Cerliponase Alfa.

Christina Due et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.